Comment on “A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 – 2023”

titled 'A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 to 2023' in Human Vaccines & Immunotherapeutics with great interest.In this study, Qing Huang et al. further improved Miao et al.' s bibliometrics study 2 in the whole field of CAR T cells, focusing on the relevant studies of CAR T therapy for hematological malignancies (excluding literatures related to solid tumors).Six emerging themes are identified that are the prevailing research hotspots, which may provide more targeted guidance and valuable references for researchers in the field of CAR-T cell therapy for hematological malignancies.However, there are several figures in the paper that may require further confirmation.

Authors

Institutions

Publication Details

Journal
Human Vaccines & Immunotherapeutics
Published
2024-10-22
DOI
https://doi.org/10.1080/21645515.2024.2408881
Citations
1
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.28

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comment on “A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 – 2023”

Kun Xu, Hua Zhao, Jiayue Xu, Yuejun Zhou
1 citations
Human Vaccines & Immunotherapeutics
CAR-T cell therapy research
0.28
article

Comment on “A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 – 2023”

Kun Xu, Hua Zhao, Jiayue Xu, Yuejun Zhou
article en
1 citations

Abstract

titled 'A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 to 2023' in Human Vaccines & Immunotherapeutics with great interest.In this study, Qing Huang et al. further improved Miao et al.' s bibliometrics study 2 in the whole field of CAR T cells, focusing on the relevant studies of CAR T therapy for hematological malignancies (excluding literatures related to solid tumors).Six emerging themes are identified that are the prevailing research hotspots, which may provide more targeted guidance and valuable references for researchers in the field of CAR-T cell therapy for hematological malignancies.However, there are several figures in the paper that may require further confirmation.

Human Vaccines & ImmunotherapeuticsVol. 20(1)
Zhejiang Chinese Medical University (CN)
Zhejiang Chinese Medical University
Openalex Percentile: Top 35%
CAR-T cell therapy research
0.28
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.